Luminex (NSDQ:LMNX) announced today that it received FDA emergency use authorization (EUA) for its xMAP SARS-CoV-2 multi-antigen IgG assay for COVID-19. Austin, Texas-based Luminex said in a news release that its serology assay can identify the presence of antibodies in those who have been infected with the SARS-CoV-2 virus causing COVID-19. The newly authorized assay can […]
Luminex wins EUA for new COVID-19 diagnostic test
Luminex (NSDQ:LMNX) announced today that it received FDA emergency use authorization (EUA) for its Aries SARS-CoV-2 assay for detecting the virus causing COVID-19. Austin, Texas-based Luminex runs the test on its FDA-cleared Aries system for sample-to-answer, automated, on-demand molecular diagnostics. Aries is capable of running up to 144 tests per day with no specialty training […]
Si-Bone tops estimates with Q4 prelims | Wall Street Beat
Si-Bone (NSDQ:SIBN) said today that it expects to record fourth-quarter sales of $15.4 million to $15.6 million, up 12 – 13% from the same period last year. The company pegged its full-year sales for 2018 between $55.2 million and $55.4 million, up 15% from 2017. Analysts on Wall Street are expecting Si-Bone to post Q4 sales […]
Sterilis taps ex-Nanosphere CEO McGarrity as chief exec | Personnel Moves – November 1, 2017
Medical sterilization company Sterilis said yesterday it tapped former Nanosphere (NSDQ:NSPH) chief exec Michael McGarrity as its new CEO. McGarrity held the CEO position at Nanosphere from February 2013 to last June when he oversaw the company’s $76.9 million acquisition by Luminex (NSDQ:LMNX). Prior to his time as head of Nanosphere, McGarrity held positions in sales, marketing […]
Luminex tops Q2 estimates
Shares in Luminex (NSDQ:LMNX) rose today after the company beat expectations on Wall Street with its second quarter results. The Austin, Tx.-based company posted profits of $5.5 million, or 13¢ per share, on sales of $76.5 million for the 3 months ended June 30, for bottom-line growth of -1.9% on sales growth of 19% compared with the […]
Luminex wins FDA nod to test for dangerous pregnancy infection
Luminex continues to rack up FDA clearances for assays to use in its Aries systems. The Austin, Texas–based company said Wednesday that FDA has cleared an Aries assay for group B streptococcus. It’s the third assay FDA has cleared for use with Luminex’s Aries systems. The GBS assay has also received a CE-IVD marking. Luminex […]
